Evidence map›Paper›PMID 25740524›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Obesity is associated with decreased μ-opioid but unaltered dopamine D2 receptor availability in the brain.

Henry K Karlsson, Lauri Tuominen, Jetro J Tuulari, Jussi Hirvonen, Riitta Parkkola, Semi Helin, Paulina Salminen, Pirjo Nuutila, Lauri Nummenmaa

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 5 pooled it
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 5 syntheses or guidelines pooled it, 233 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Trial
  8. Dopamine Depletion Reduces Food-Related Reward Activity Independent of BMI.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Trial
  9. Trial
  10. Article
  11. Article
  12. Infarct-Limiting Efficacy of the μBulletin of experimental biology and medicine · 2026
    Article
  13. Aberrant type 2 dopamine and mu-opioid receptor availability in autism spectrum disorder.European journal of nuclear medicine and molecular imaging · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Henry K KarlssonTurku PET Centre, and lauri.nummenmaa@aalto.fi hekrka@utu.fi.
Lauri TuominenTurku PET Centre, and Departments of Psychiatry.
Jetro J TuulariTurku PET Centre, and.
Jussi HirvonenTurku PET Centre, and Radiology.
Riitta ParkkolaRadiology.
Semi HelinTurku PET Centre, and.
Paulina SalminenSurgery, and.ORCID http://orcid.org/0000-0001-6435-9264
Pirjo NuutilaTurku PET Centre, and Endocrinology, Turku University Hospital, FI-20520 Turku, Finland, and.
Lauri NummenmaaTurku PET Centre, and Department of Neuroscience and Biomedical Engineering, School of Science, Aalto University, FI-00076 Aalto, Finland lauri.nummenmaa@aalto.fi hekrka@utu.fi.
Nature Conservation Centre · TRTurku University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurochemical pathways involved in pathological overeating and obesity are poorly understood. Although previous studies have shown increased μ-opioid receptor (MOR) and decreased dopamine D2 receptor (D2R) availability in addictive disorders, the role that these systems play in human obesity still remains unclear. We studied 13 morbidly obese women [mean body mass index (BMI), 42 kg/m(2)] and 14 nonobese age-matched women, and measured brain MOR and D2R availability using PET with selective radioligands [(11)C]carfentanil and [(11)C]raclopride, respectively. We also used quantitative meta-analytic techniques to pool previous evidence on the effects of obesity on altered D2R availability. Morbidly obese subjects had significantly lower MOR availability than control subjects in brain regions relevant for reward processing, including ventral striatum, insula, and thalamus. Moreover, in these areas, BMI correlated negatively with MOR availability. Striatal MOR availability was also negatively associated with self-reported food addiction and restrained eating patterns. There were no significant differences in D2R availability between obese and nonobese subjects in any brain region. Meta-analysis confirmed that current evidence for altered D2R availability in obesity is only modest. Obesity appears to have unique neurobiological underpinnings in the reward circuit, whereby it is more similar to opioid addiction than to other addictive disorders. The opioid system modulates motivation and reward processing, and low μ-opioid availability may promote overeating to compensate decreased hedonic responses in this system. Behavioral and pharmacological strategies for recovering opioidergic function might thus be critical to curb the obesity epidemic.

Indexed as

AdultAnatomy, Cross-SectionalBrain ChemistryEatingHumansImage Processing, Computer-AssistedObesity, MorbidPositron-Emission TomographyReceptors, Dopamine D2Receptors, Opioid, muSurveys and QuestionnairesReceptors, Dopamine D2Receptors, Opioid, mudopamineobesityopioidspositron emission tomographyreceptorsreward

Identifiers

PMID25740524
PMCPMC6605573
OpenAlexW2040052591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.